GeneDx Holdings WGS Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation?
- GeneDx Holdings (WGS) reported cash provided by (used in) financing activity, including discontinued operation of $38.59M in Q1 2026.
- How has GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation increased by 181.3% year-over-year, from $13.72M to $38.59M.
- What is the long-term trend for GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation?
- Over 4 years (2021 to 2025), GeneDx Holdings's cash provided by (used in) financing activity, including discontinued operation has grown at a -44.2% compound annual growth rate (CAGR), from $494.76M to $48.03M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.